Development of industrial biocatalysts and therapeutic polypeptides by protein engineering (Q3712427)

From EU Knowledge Graph
Revision as of 19:17, 24 November 2021 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
Jump to navigation Jump to search
Project Q3712427 in France
Language Label Description Also known as
English
Development of industrial biocatalysts and therapeutic polypeptides by protein engineering
Project Q3712427 in France

    Statements

    0 references
    1,583,958.57 Euro
    0 references
    2,828,497.44 Euro
    0 references
    56.0 percent
    0 references
    17 June 2016
    0 references
    31 December 2019
    0 references
    SAS PEACCEL
    0 references
    0 references
    Le projet de la société « PEACCEL » consiste au développement et à l'optimisation d'une plateforme virtuelle permettant d'effectuer la synthèse de molécules à destination de secteurs de la pharmaceutique, de l'agroalimentaire, du biogaz,… (French)
    0 references
    The project of the company “PEACCEL” consists of the development and optimisation of a virtual platform enabling the synthesis of molecules for the pharmaceutical, agri-food, biogas sectors, etc. (English)
    22 November 2021
    0 references

    Identifiers

    RE0006507
    0 references